Literature DB >> 30096452

Purified sulforaphane from broccoli (Brassica oleracea var. italica) leads to alterations of CDX1 and CDX2 expression and changes in miR-9 and miR-326 levels in human gastric cancer cells.

Sholeh Kiani1, Haleh Akhavan-Niaki2, Sadegh Fattahi3, Saeid Kavoosian3, Nadali Babaian Jelodar1, Nadali Bagheri1, Hamid Najafi Zarrini1.   

Abstract

BACKGROUND: Genetic alterations and epigenetic modifications are two main factors involved in gastric carcinogenesis, progression, and metastasis. Several miRNAs such as miRNA-9 and miRNA-326 may play important role in gastric cancer by targeting the 3'UTR of the caudal type homeobox (CDX) 1 and 2 mRNA respectively. The use of herbal medicines has been widely considered in the treatment of cancers such as gastric cancer. Sulforaphane extracted from broccoli may indirectly prevent cancer through affecting different signaling pathways. The aim of this study was to evaluate the effect of different concentrations of sulforaphane extracted from broccoli sprout (SEBS) on viability, death pattern, and expression alterations of CDX1/2 as well as miRNA-9 and miRNA-326 in normal (HF2FF) and gastric cancer cell lines.
METHODS: Two gastric cancer cell lines (AGS and MKN45) and HF2FF normal cell line were cultured and treated with different concentrations (31.25, 62.5, 125, and 250 μg/ml) of the purified sulforaphane. Expression levels of CDX1 and CDX2 as well as miRNA-9 and miRNA-326, and mechanisms leading to cell death were assessed by Taqman real time PCR assay and flow cytometry, respectively.
RESULTS: Significant dose-dependent and anti-proliferative effects of the SEBS were observed on AGS and MKN45 cells after 48 h with an IC50 value of about 112 and 125 μg/ml, respectively (P < 0.001). Apoptotic cells were observed in AGS and MKN45 cells but not HF2FF after 48 h of treatment with SEBS. Furthermore, significant changes in expression of CDX1, CDX2, miR-9 and miR-326 in the gastric cancer lines (AGS and MKN45), were observed under different concentrations of SEBS.
CONCLUSION: Our present study suggests that the SEBS may influence gastric cancer cell lines at specific doses and change their proliferation rate by altering the expression of CDX1, CDX2, miR-9, and miR-326.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CDX1; CDX2; Epigenetic alteration; Gastric cancer; Sulforaphane; miR-326; miR-9

Mesh:

Substances:

Year:  2018        PMID: 30096452     DOI: 10.1016/j.gene.2018.08.026

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  Cancer and Traditional Plant Knowledge, an Interesting Field to Explore: Data from the Catalan Linguistic Area.

Authors:  Airy Gras; Montse Parada; Jaume Pellicer; Joan Vallès; Teresa Garnatje
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

Review 2.  The Glucosinolates: A Sulphur Glucoside Family of Mustard Anti-Tumour and Antimicrobial Phytochemicals of Potential Therapeutic Application.

Authors:  James Melrose
Journal:  Biomedicines       Date:  2019-08-19

Review 3.  Research Progress in microRNA-Based Therapy for Gastric Cancer.

Authors:  Xu Zhao; Gao-Feng Hu; Yan-Fen Shi; Wei Xu
Journal:  Onco Targets Ther       Date:  2019-12-24       Impact factor: 4.147

4.  Sulforaphane induces S-phase arrest and apoptosis via p53-dependent manner in gastric cancer cells.

Authors:  Yuan Wang; Huazhang Wu; Nannan Dong; Xu Su; Mingxiu Duan; Yaqin Wei; Jun Wei; Gaofeng Liu; Qingjie Peng; Yunli Zhao
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

5.  Therapeutic Mechanism of Lapatinib Combined with Sulforaphane on Gastric Cancer.

Authors:  Huixing Yi; Zheming Li; Xiaoxi Liu; Shijie Dai; Shouye Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-18       Impact factor: 2.629

Review 6.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 7.  Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Soheil Hassanipour; Hamid Salehiniya
Journal:  Clin Exp Gastroenterol       Date:  2020-11-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.